Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | XXII 0.1977 -8.34% | SHFS 0.1324 -61.39% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | YFOR 0.2236 -1.58% | RBNE 0.19 -2.56% | TQQQ 66.29 -0.20% | VZ 44.66 -1.19% | TSLL 9.76 -1.21% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | SQQQ 39.68 0.20% | AIOK 12.02 182.82% | ONDS 6.2 2.99% | AAPL 347.725 -0.14% | LABT 0.31 -36.67% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | GRAB 2.79 -2.11% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | IREN 24.905 -2.37% | QID 14.55 0.14% | RKT 11.73 -0.09% | WULF 11.32 0.00% | BE 193.3 -11.24%
SOSOPHiA GENETICS S.A. logo

SOPHiA GENETICS S.A. (SOPH)

NASDAQ Global Select · Currency in USD
$7.35 ▲ +0.30 (+4.26%)
At close: Oct 23, 4:00 PM ET. Market closed.
$7.48 ▲ +0.13 (+1.77%)
After hours: Oct 23, 7:30 PM ET

Summary

Previous Close
$7.05
Open
$6.99
Day's Range
$6.94 – $7.41
52 Week Range
$3.83 – $8.98
Volume
455,213
Avg. Volume
540,913
Market Cap
$625.69M
Beta (5Y Monthly)
0.95
PE Ratio (TTM)
--
EPS (TTM)
-$1.10
Earnings Date
Nov 3, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
$11.50

Profile: SOPHiA GENETICS S.A.

Sector
Healthcare
Industry
Medical - Healthcare Information Services
Full-time employees
415
CEO
Ross Muken

SOPHiA GENETICS S.A. operates as a specialized company within the healthcare technology sector. The firm provides the SOPHiA DDM platform, a cloud-native Software-as-a-Service (SaaS) solution engineered to analyze diverse multimodal datasets and various diagnostic inputs, thereby extracting valuable insights. This platform, together with its related offerings and services, is widely adopted by hospitals, laboratories, and biopharmaceutical organizations across the globe.

Earnings

Next report: Tue, Nov 3, 2026
EPS estimate -$0.20 · Revenue est. $24.03M
DateEst.Actual
Aug 4, 2026-$0.21-$0.26Miss
May 5, 2026-$0.23-$0.27Miss
Mar 3, 2026-$0.24-$0.28Miss
Nov 4, 2025-$0.20-$0.30Miss
Aug 5, 2025-$0.21$0.33Beat
May 6, 2025-$0.21-$0.26Miss

Analyst view

Consensus price target
$11.50 ▲ +56.5%
Range $9.00 – $14.00
Rating: Buy
Buy 88% · Hold 13% · Sell 0%

Get free alerts on SOPH and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.